BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29663172)

  • 21. Neurocognitive evaluation of brain metastases patients treated with post-resection stereotactic radiosurgery: a prospective single arm clinical trial.
    Berger A; Strauss I; Ben Moshe S; Corn BW; Limon D; Shtraus N; Shahar T; Kanner AA
    J Neurooncol; 2018 Nov; 140(2):307-315. PubMed ID: 30078070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer.
    Lagerwaard FJ; Aaronson NK; Gundy CM; Haasbeek CJ; Slotman BJ; Senan S
    J Thorac Oncol; 2012 Jul; 7(7):1148-54. PubMed ID: 22610256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone.
    Chang EL; Wefel JS; Maor MH; Hassenbusch SJ; Mahajan A; Lang FF; Woo SY; Mathews LA; Allen PK; Shiu AS; Meyers CA
    Neurosurgery; 2007 Feb; 60(2):277-83; discussion 283-4. PubMed ID: 17290178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.
    Rahman Z; Wong CH; Dexter M; Olsson G; Wong M; Gebsky V; Nahar N; Wood A; Byth K; King M; Bleasel AB
    Epilepsy Behav; 2015 Jul; 48():88-95. PubMed ID: 26136184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of health-related quality of life in Lithuanian brain tumor patients using the EORTC brain cancer module.
    Bunevičius A; Tamašauskas Š; Tamašauskas A; Deltuva V
    Medicina (Kaunas); 2012; 48(11):588-94. PubMed ID: 23455894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
    Taphoorn MJ; Stupp R; Coens C; Osoba D; Kortmann R; van den Bent MJ; Mason W; Mirimanoff RO; Baumert BG; Eisenhauer E; Forsyth P; Bottomley A; ; ;
    Lancet Oncol; 2005 Dec; 6(12):937-44. PubMed ID: 16321761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
    Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
    Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control.
    Miyakawa A; Shibamoto Y; Takemoto S; Serizawa T; Otsuka S; Hirai T
    Int J Clin Oncol; 2017 Apr; 22(2):250-256. PubMed ID: 27826659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term health-related quality of life and neurocognitive functioning after treatment in skull base meningioma patients.
    Fisher FL; Zamanipoor Najafabadi AH; van der Meer PB; Boele FW; Peerdeman SM; Peul WC; Taphoorn MJB; Dirven L; van Furth WR
    J Neurosurg; 2022 Apr; 136(4):1077-1089. PubMed ID: 34598137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases.
    Wong E; Zhang L; Kerba M; Arnalot PF; Danielson B; Tsao M; Bedard G; Thavarajah N; Cheon P; Danjoux C; Pulenzas N; Chow E
    Support Care Cancer; 2015 Sep; 23(9):2731-7. PubMed ID: 25663577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long Study.
    Van Der Weijst L; Surmont V; Schrauwen W; Lievens Y
    Front Oncol; 2021; 11():685605. PubMed ID: 34222010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
    Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
    Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between cognitive functioning, mood, and other patient factors on quality of life in metastatic brain cancer.
    Marotta D; Tucker Z; Hayward EN; Gerstenecker A; Gammon M; Mason M; Willhelm G; Bae H; Triebel K
    Psychooncology; 2020 Jul; 29(7):1174-1184. PubMed ID: 32364662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.
    Chiu L; Chiu N; Zeng L; Zhang L; Popovic M; Chow R; Lam H; Poon M; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):831-7. PubMed ID: 23252363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of thyroid hormone concentrations with quality of life of primary brain tumor patients: a pilot study.
    Bunevicius A; Laws ER; Deltuva V; Tamasauskas A
    J Neurooncol; 2017 Jan; 131(2):385-391. PubMed ID: 27830477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic effect of gamma-ray stereotactic radiotherapy on brain metastases].
    Wei R; Ma ZM; Yuan J
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):451-2. PubMed ID: 12536499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients.
    van Stam MA; Aaronson NK; Pos FJ; Bosch JL; Kieffer JM; Tillier CN; van der Poel HG
    Eur Urol; 2016 Nov; 70(5):751-757. PubMed ID: 27016464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.